Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

What to Expect From Pfizer's Q3 2024 Earnings Report

Pfizer is expected to release its fiscal third-quarter earnings later this month, and analysts project a triple-digit profit growth.

Should You Follow Activist Investors Into This High-Yield Dividend Stock?

Should You Follow Activist Investors Into This High-Yield Dividend Stock?

This dividend stock is now on the radar of activist investors, with Starboard eyeing a possible management shakeup.

‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines

‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines

Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Nvidia's 84% Expected Profit Growth Looms Large In S&P 500

Nvidia is expected to boost the S&P 500 Q3 earnings growth rate. Meta Platforms and Alphabet may lift Communications Services earnings.

Investors Business Daily

How To Spot Good Value Stocks In A Sea Of Noise

Explore why traditional value investing often falls short and how catalysts can transform undervalued stocks into lucrative investments.

Stock Market Rallies As S&P 500, Dow Hit Highs; Tesla Robotaxi Isn't Hailed, Delta, JPMorgan In Focus: Weekly Review

The stock market had a key week, as the S&P 500 and Dow hit record highs. The Tesla robotaxi failed to wow, but many leaders broke out.

Investors Business Daily

Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis

'Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff Sonnenfeld and Steven Tian.

inkl

Read news from The Economist, FT, and more,
with one subscription

Stock Market Today: Markets Slip on Hot Inflation Print, Layoff News

Stock Market Today: Markets Slip on Hot Inflation Print, Layoff News

Economic data continues to complicate expectations for Federal Reserve rate cuts.

Pfizer Skids After Former Execs Flip On Starboard; Activist Investor Says They Were Coerced

Pfizer Skids After Former Execs Flip On Starboard; Activist Investor Says They Were Coerced

Pfizer stock skidded Thursday after former executives Ian Read and Frank D'Amelio sided with the drugmaker over activist investor Starboard.

Investors Business Daily

3 High-Yield Stocks for Growing Dividend Income

3 High-Yield Stocks for Growing Dividend Income

Each of these companies boasts a solid track record of paying and raising dividends, with yields exceeding 5%.

Is This Overlooked Dividend Stock Yielding Almost 6% a Good Turnaround Play?

Is This Overlooked Dividend Stock Yielding Almost 6% a Good Turnaround Play?

Despite its dividend yield of nearly 6%, Pfizer stock has failed to win over investors and is in the red YTD. Can the stock finally stage a turnaround, as activist investor Starboard Value has reportedly taken a stake in the company?

2 Covered Call Ideas on Pfizer Stock

2 Covered Call Ideas on Pfizer Stock

Today, we’re looking at two covered call examples on Pfizer stock. The first step to finding our covered call candidates is to use the Stock Scanner with the following parameters:

One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics

One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the seventh-deadliest pandemic in recorded history.

The Conversation

Pfizer stock surges after activist takes $1 billion stake

Pfizer stock surges after activist takes $1 billion stake

The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic waned.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Drops 400 Points, But Supermicro Soars As Nvidia Clears Entry; Cathie Wood Sells AI Chipmaker After 74% Gain (Live Coverage)

Dow Jones and other indexes fell in early trades Monday as yields surged. Nvidia gained and cleared a trendline entry as Tesla fell ahead of the Robotaxi event.

Investors Business Daily

Pfizer Jumps After Activist Investor Starboard Reportedly Takes $1 Billion Stake

Pfizer stock popped Monday on a report activist investor Starboard Value took a roughly $1 billion stake in the struggling drugmaker.

Investors Business Daily

Dow Jones Falls As Treasury Yields Top 4%; Apple IPhone Expectations 'Too High'

The Dow Jones fell on the stock market today as the 10-year Treasury yield topped 4%. Analysts Apple and Netflix. The Tesla robotaxi looms.

International Business Times

Activist Starboard Takes $1 Billion Stake In Pfizer, Seeks Former Execs' Support: Reports

Starboard has reached out to former Pfizer CEO Ian Read and ex-finance chief Frank D'Amelio, and both have expressed interest in supporting the activist investor's turnaround efforts, reports said.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

I thought I was fine with being bald. But the chance of a cure has stirred up all sorts of feelings

It’s almost 30 years since I lost my hair to alopecia. What if Pfizer’s drug Litfulo could bring it back? asks Guardian columnist Emma Beddington

RSV can be deadly—especially for older adults. Why aren’t more of them getting the new vaccine?

About 6,000 to 10,000 people 65 and older die from RSV in the U.S. annually, the CDC says.

Investors Business Daily

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer

Viking Therapeutics stock is on the rise as the battle to develop new weight-loss drugs heats up. Here's what's at stake for the pharma giants fighting for position.

What You Need to Know Ahead of Walgreens Boots Alliance's Earnings Release

With Walgreens Boots Alliance gearing up to release its fourth-quarter earnings later this month, analysts expect a double-digit earnings dip.

How to Buy PFE For a 6% Discount, or Achieve a 23% Annual Return

Selling cash secured puts on stocks an investor is happy to take ownership of is a great way to generate some extra income.

3 Dividend Stocks Yielding 5% To 11% To Scoop Up Now

These three stocks pay out an attractive yield.

Investors Business Daily

Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.

Pfizer stock closed flat Thursday after the company pulled its sickle cell drug, Oxbryta, from the market following patient deaths.

1 … 8 9 10 11

People

Emma Beddington

Christopher Raymond

Robert Hopkins Jr

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

304,116 stories

121,785 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play